More than a hundred teachers and staff from Banks' three public schools gathered in the Banks Elementary School cafeteria Aug. 19 for a breakfast with their peers and school officials as another ...

The bull market in U.S. stocks has been broadening as investors anticipate the Federal Reserve will lower interest rates in September, with the equal-weight version of the S&P 500 booking its longest ...

Following the broader Material 3 Expressive redesign last week, the Google Phone app is now more widely rolling out calling cards.

Browse 9,200+ cell phone alphabet stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art.

It is noteworthy that Apple has not kept pace with rivals such as OpenAI, Alphabet, and Microsoft in publicly launching AI capabilities, but Cook displayed an intrepid confidence in the company ...

Alphabet Inc. (NASDAQ:GOOGL) ranks among the best stocks to buy for the next 6 months. JPMorgan maintained its Overweight rating and $232 price target on Alphabet Inc. (NASDAQ:GOOGL) on July 28 ...

Analysts raise Alphabet's stock price targets Alphabet’s latest earnings beat has prompted a wave of price target hikes from Wall Street analysts, though opinions split on how much upside is left.

Sundar Pichai, CEO of Alphabet Inc., has achieved a significant personal financial milestone, with his net worth now exceeding $1.1 billion, according to the Bloomberg Billionaires Index. This ...

Alphabet posted its second-quarter earnings after Wednesday's closing bell, beating on the headline numbers and giving a higher forecast for this year's capital expenditures. But some analysts say ...

Alphabet (Nasdaq:GOOG) reports Q2 2025 earnings after the market closes tonight. The Street expects strong double-digit top-line growth driven by continued strength in Search, YouTube, and AI ...

Going Into Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued? With the monetization of GenAI, here’s what we think of Alphabet’s stock ...

Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.